LOSE WEIGHT WITH MEDICAL SUPPORT — BUILT FOR MEN
- Your personalised programme is built around medical care, not willpower.
- No generic diets. No guesswork.
- Just science-backed results and expert support.
Find out if you’re eligible
Zepbound (tirzepatide) is an FDA-approved dual GIP and GLP-1 receptor agonist for chronic weight management in adults with obesity or overweight with weight-related comorbidities. While highly effective, constipation affects approximately 11-16% of patients, primarily due to slowed gastric emptying and reduced intestinal motility. Understanding how to prevent and manage this common side effect is essential for treatment adherence and quality of life. This guide provides evidence-based strategies including dietary modifications, hydration practices, lifestyle interventions, and appropriate use of over-the-counter remedies to maintain bowel regularity while taking Zepbound.
Quick Answer: Prevent constipation on Zepbound by increasing dietary fiber to 25-38 grams daily, maintaining adequate hydration (2.7-3.7 liters daily), engaging in regular physical activity, and using over-the-counter fiber supplements or osmotic laxatives when needed.
Zepbound (tirzepatide) is a dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist approved by the FDA for chronic weight management in adults with obesity (BMI ≥30 kg/m²) or overweight (BMI ≥27 kg/m²) with at least one weight-related comorbidity. While effective for weight loss, constipation is a recognized gastrointestinal adverse effect, affecting approximately 11-16% of patients depending on dose, according to the FDA prescribing information.
The mechanism underlying constipation with Zepbound primarily relates to GLP-1 receptor activation, which slows gastric emptying and reduces intestinal motility. These effects contribute to increased satiety and reduced caloric intake—key factors in weight loss efficacy. However, this delayed transit time throughout the digestive system can result in harder, less frequent stools. The GIP component may also influence gut motility, though its specific contribution to constipation is less well characterized than the GLP-1 effects.
Additionally, patients taking Zepbound often experience reduced appetite and decreased food intake, which naturally results in lower stool volume and frequency. Dietary changes associated with weight loss efforts—such as reduced fiber intake or caloric restriction—can further compound constipation risk. Inadequate fluid intake can also contribute to constipation.
It is important to note that constipation severity varies considerably among individuals. Most cases are mild to moderate and manageable with appropriate preventive strategies. Gastrointestinal side effects, including constipation, are most common during dose escalation and often improve with continued use. Understanding these mechanisms allows patients and healthcare providers to implement targeted interventions that maintain bowel regularity while preserving the therapeutic benefits of Zepbound.
LOSE WEIGHT WITH MEDICAL SUPPORT — BUILT FOR MEN
Find out if you’re eligible
Dietary modification represents the first-line approach to preventing constipation in patients taking Zepbound. Increasing dietary fiber intake is the most evidence-based intervention. According to the National Academies of Sciences, Engineering, and Medicine, recommended fiber intake is approximately 25 grams daily for women and 38 grams daily for men (or about 14 grams per 1,000 calories consumed). Soluble fiber sources such as oats, psyllium, chia seeds, and legumes absorb water and form a gel-like substance that softens stools and promotes regular bowel movements. Insoluble fiber from vegetables, whole grains, and wheat bran adds bulk to stool and accelerates intestinal transit time.
Patients should introduce fiber gradually—increasing intake by 5 grams every few days—to minimize bloating and gas, which can be particularly uncomfortable when combined with Zepbound's gastrointestinal effects. Those with irritable bowel syndrome or sensitivity to FODMAPs may prefer psyllium or oat-based fibers, which are generally better tolerated.
Key fiber-rich foods to emphasize:
Legumes (lentils, black beans, chickpeas): 7–8 grams per half cup
Raspberries and blackberries: 4–8 grams per cup
Avocado: 10 grams per medium fruit
Broccoli and Brussels sprouts: 4–5 grams per cup cooked
Whole-grain products: 3–5 grams per serving
Prunes and prune juice deserve special mention as they contain both fiber and sorbitol, a natural sugar alcohol with mild laxative properties. Consuming 4–6 prunes daily or 4–8 ounces of prune juice can effectively promote bowel regularity. Patients should be mindful that while reducing overall caloric intake for weight loss, maintaining adequate fiber consumption remains essential for gastrointestinal health. Working with a registered dietitian can help balance weight management goals with optimal bowel function while taking Zepbound.
Adequate hydration is critical for preventing constipation in patients taking Zepbound, as water softens stool and facilitates its passage through the intestinal tract. According to the National Academies of Sciences, Engineering, and Medicine, total daily water intake recommendations are approximately 3.7 liters (about 125 ounces) for men and 2.7 liters (about 91 ounces) for women from all sources, including beverages and food. Individual needs vary based on body weight, activity level, and climate. Patients should increase fluid intake proportionally when increasing dietary fiber, as fiber requires water to exert its beneficial effects on stool consistency.
Beyond plain water, other hydrating beverages include herbal teas, clear broths, and water-rich foods such as cucumbers, watermelon, and citrus fruits. Warm liquids, particularly in the morning, can stimulate bowel activity through the gastrocolic reflex. Moderate caffeine consumption is generally acceptable and may even stimulate bowel movements in some individuals. However, patients with fluid restrictions (such as those with heart failure or kidney disease) should consult their healthcare provider about appropriate fluid intake.
Physical activity represents another essential lifestyle intervention for maintaining bowel regularity. Regular exercise stimulates intestinal contractions and reduces the time stool remains in the colon. The U.S. Department of Health and Human Services recommends 150-300 minutes of moderate-intensity aerobic activity weekly, which also supports weight loss goals. Even light activities such as walking for 20–30 minutes daily can significantly improve bowel function.
Additional lifestyle strategies include:
Establishing a consistent bathroom routine, ideally after meals when the gastrocolic reflex is strongest
Allowing adequate time for bowel movements without rushing
Responding promptly to the urge to defecate rather than delaying
Elevating feet on a small stool while sitting on the toilet to optimize anorectal angle
Managing stress through relaxation techniques, as psychological factors can influence gut motility
These combined hydration and lifestyle approaches work synergistically with dietary modifications to prevent constipation while taking Zepbound.
When dietary and lifestyle modifications prove insufficient, over-the-counter (OTC) remedies can provide additional support for managing constipation in patients taking Zepbound. Fiber supplements such as psyllium (Metamucil), methylcellulose (Citrucel), or wheat dextrin (Benefiber) offer a convenient way to increase fiber intake, particularly for patients struggling to meet targets through diet alone. These should be taken with adequate water—at least 8 ounces per dose—and started at low doses to assess tolerance.
Osmotic laxatives represent a safe, effective option for regular use if needed. Polyethylene glycol 3350 (MiraLAX) draws water into the colon to soften stool and is generally well-tolerated for longer-term use. Magnesium-based products (milk of magnesia) work similarly but should be used cautiously in patients with kidney disease. Stool softeners such as docusate sodium (Colace) may provide modest benefit, though evidence for their efficacy is limited compared to other agents.
Stimulant laxatives like bisacodyl (Dulcolax) or senna are best used as rescue therapy or for short-term relief rather than daily management, as they may cause cramping and are generally recommended for intermittent use. For acute, refractory constipation, glycerin suppositories can provide more immediate relief.
Patients should contact their healthcare provider if they experience:
Severe or worsening abdominal pain
Persistent constipation despite OTC interventions
Fever with abdominal pain
Rectal bleeding, black or tarry stools
Persistent vomiting or inability to pass gas
Unintentional weight loss beyond expected therapeutic effects
New or worsening symptoms after starting Zepbound
These symptoms may indicate complications requiring medical evaluation. If constipation is significant, healthcare providers may recommend slowing the Zepbound dose titration, temporarily maintaining the current dose longer, or considering a dose reduction. Patients should never adjust their Zepbound dosing independently without medical guidance, as maintaining appropriate therapeutic levels is important for both efficacy and tolerability.
For patients continuing Zepbound long-term, establishing sustainable bowel health practices is essential for treatment adherence and quality of life. Gastrointestinal side effects, including constipation, are most common during dose escalation and tend to improve over time as the body adapts to the medication. However, some patients may experience persistent symptoms requiring ongoing management strategies.
Regular monitoring and communication with healthcare providers allow for proactive adjustments to prevention strategies. Patients should track bowel movement frequency, stool consistency (using tools like the Bristol Stool Chart), and any associated symptoms in a diary or health app. This information helps healthcare providers identify patterns and optimize management approaches. Periodic reassessment of fiber intake, hydration status, and physical activity levels ensures these foundational interventions remain adequate as weight loss progresses and dietary patterns evolve.
For patients requiring ongoing laxative use, polyethylene glycol remains the preferred agent due to its safety profile and consistent effectiveness over time. However, the goal should be to use the minimum effective intervention, gradually reducing reliance on pharmacologic agents as lifestyle modifications become established habits. Some patients benefit from scheduled "bowel training" programs that leverage the gastrocolic reflex by attempting defecation 15–30 minutes after meals, particularly breakfast.
Long-term considerations include:
Follow-up with healthcare providers based on symptom burden
Screening for other contributing factors such as hypothyroidism, diabetes-related neuropathy, or medication interactions
Nutritional assessment to ensure adequate micronutrient intake despite reduced food consumption
Evaluation for pelvic floor dysfunction if constipation persists despite optimal management
Discussion of prescription medications (such as lubiprostone, linaclotide, plecanatide, or prucalopride) if OTC and lifestyle measures are insufficient
Patients should understand that maintaining bowel regularity while taking Zepbound is achievable with appropriate strategies. Collaborative decision-making between patients and healthcare providers ensures individualized approaches that balance therapeutic goals with gastrointestinal comfort and overall well-being.
Zepbound causes constipation primarily through GLP-1 receptor activation, which slows gastric emptying and reduces intestinal motility. This delayed transit time throughout the digestive system, combined with reduced food intake and appetite suppression, results in harder, less frequent stools.
Polyethylene glycol 3350 (MiraLAX) is the preferred over-the-counter option for managing constipation on Zepbound due to its safety profile and effectiveness for longer-term use. Fiber supplements like psyllium can also help when dietary fiber intake is insufficient.
Contact your healthcare provider if you experience severe or worsening abdominal pain, persistent constipation despite over-the-counter interventions, rectal bleeding, fever with abdominal pain, persistent vomiting, or inability to pass gas. These symptoms may indicate complications requiring medical evaluation.
All medical content on this blog is created using reputable, evidence-based sources and is regularly reviewed for accuracy and relevance. While we strive to keep our content current with the latest research and clinical guidelines, it is intended for general informational purposes only.
This content is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a licensed healthcare provider with any medical questions or concerns. Use of this information is at your own risk, and we are not liable for any outcomes resulting from its use.
